Thursday 8 April 2021

Covid vaccination at works places having 100 or more beneficiaries


Ministry of Health and Family Welfare
Centre issues Guidance Note to operationalise COVID Vaccination Centres at Work Places (Govt. and Private)

From 11 April 2021 all Employees of Work Places aged 45 yrs or more to be Vaccinated at Work Place Vaccination centres

Posted On: 07 APR 2021 7:02PM by PIB Delhi

With the extension of COVID-19 vaccination to all citizens aged 45 years or more from 1st April 2021, the Central Government has taken a crucial step to extend the cover of vaccination while easing the exercise for this segment of citizens, a substantial proportion of whom are in the organized sector of the economy and are involved in formal occupation in offices (government and private) or manufacturing and services etc.

The Health Ministry has written to all States and UTs that COVID-19 vaccination sessions may now be organized at workplaces (both public & private) which are having about 100 eligible and willing beneficiaries by tagging these workplaces with an existing COVID Vaccination Center (CVC). To support the States in this initiative, guidelines have been prepared and the same have conveyed by the Union Health Secretary to the States and UTs. These guidelines will support the State and District Programme Managers with the requisite information and guide them on organizing vaccination sessions at such workplaces (both public & private). Such work place vaccination centres may be launched across States/UTs from 11th April 2021.

States have been further advised to initiate due consultations with private/public sector employers and management to prepare for launch of workplace vaccination.

The Union Government of India in constant consultation with State Governments/UT administration continues consistently make efforts to ensure that the vaccination drive is more pragmatic and also more acceptable and purposeful to the beneficiaries.  Click here to read full article

👉Guidance Note for Co-Win 2.0.PDF

👉Operational Guidelines - COVID-19 Vaccines.PDF

No comments: